Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 2,664,000 | 2,842,000 | 2,233,570 | 1,872,282 | 1,462,043 |
| Cost of Goods | 832,000 | 986,000 | 734,840 | 550,379 | 400,966 |
| Gross Profit | 1,832,000 | 1,856,000 | 1,498,730 | 1,321,903 | 1,061,077 |
| Operating Expenses | 1,252,000 | 1,131,000 | 1,040,060 | 877,924 | 609,074 |
| Operating Income | 580,000 | 725,000 | 459,510 | 444,358 | 452,969 |
| Interest Expense | 70,000 | 118,000 | 67,570 | 14,285 | 11,184 |
| Other Income | 17,000 | -45,000 | -667,250 | -171,405 | -144,814 |
| Pre-tax Income | 527,000 | 562,000 | -275,310 | 258,668 | 296,971 |
| Income Tax | 154,000 | 191,000 | -10,940 | 98,254 | 129,865 |
| Net Income Continuous | 373,000 | 364,000 | 262,631 | 245,468 | 280,606 |
| Net Income Discontinuous | N/A | 0 | 0 | -21,080 | 0 |
| Net Income | $373,000 | $371,000 | $-264,360 | $139,334 | $167,106 |
| EPS Basic Total Ops | 0.46 | 0.45 | -0.34 | 0.18 | 0.23 |
| EPS Basic Continuous Ops | 0.46 | 0.44 | 0.34 | 0.32 | 0.39 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.03 | N/A |
| EPS Diluted Total Ops | 0.46 | 0.45 | -0.34 | 0.14 | 0.23 |
| EPS Diluted Continuous Ops | 0.46 | 0.44 | 0.34 | 0.31 | 0.39 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.03 | N/A |
| EBITDA(a) | $761,000 | $903,000 | $588,110 | $531,050 | $514,369 |